Atlas Trials

A Multicenter, Retrospective Observational Study to Evaluate the Effectiveness and Safety of Polatuzumab Vedotin

Clinical trial NCT04624893 · UNKNOWN

Trial details

NCT number
NCT04624893
Sponsor
Jiangsu Cancer Institute & Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Diffuse Large B-Cell Lymphoma (DLBCL)
Start date
2019-12-12
Primary completion
2020-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.